Search

Is Part Of Cancer. Volume 127:Issue 8(2021)

7. BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study. Issue 8 (3rd December 2020)

Authors:
Borthakur, Gautam; Ofran, Yishai; Tallman, Martin S.; Foran, James; Uy, Geoffrey L.; DiPersio, John F.; Showel, Margaret M.; Shimoni, Avichai; Nagler, Arnon; Rowe, Jacob M.; Altman, Jessica K.; Abraham, Michal; Peled, Amnon; Shaw, Stephen; Bohana‐Kashtan, Osnat; Sorani, Ella; Pereg, Yaron; Foley‐...
Journal:
Cancer
Issue:
Volume 127:Issue 8(2021)
Page Start:
1246
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Issue 8 (11th December 2020)

Authors:
Dahlstrom, Kristina R.; Song, Juhee; Thall, Peter F.; Fuller, Clifton D.; Hutcheson, Katherine A.; Johnson, Faye M.; Gunn, G. Brandon; Phan, Jack; Frank, Steven J.; Morrison, William H.; Ferrarotto, Renata; Rosenthal, David I.; Sturgis, Erich M.; Garden, Adam S.
Journal:
Cancer
Issue:
Volume 127:Issue 8(2021)
Page Start:
1228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search